博瑞医药终止2024年度向特定对象发行A股股票事项并撤回申请文件

Core Viewpoint - 博瑞医药 has decided to terminate its plan to issue A-shares to specific investors and has applied to withdraw the related application documents due to current market conditions and the company's actual situation [1] Group 1: Company Decision - 博瑞医药 held its 13th meeting of the 4th Board of Directors on October 15, where it approved the resolution to terminate the A-share issuance plan [1] - The company originally intended to raise up to 500 million yuan (including principal) through this issuance, with the net proceeds aimed at supplementing working capital and repaying bank loans [1] Group 2: Rationale for Termination - The decision to terminate the issuance was made after careful consideration of the current market environment and the company's development plans [1] - 博瑞医药 emphasized the importance of protecting the interests of all shareholders, particularly small and medium-sized investors, in making this decision [1]